---
annotations:
- type: Pathway Ontology
  value: signaling pathway
authors:
- ReactomeTeam
- Egonw
- DeSl
description: The 22 members of the fibroblast growth factor (FGF) family of growth
  factors mediate their cellular responses by binding to and activating the different
  isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
  FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
  processes in which cell fate and differentiation to various tissue lineages are
  determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
  sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
  that lead to the variety of cellular responses induced by this large family of growth
  factors. An alternative, FGF-independent, source of FGFR activation originates from
  the interaction with cell adhesion molecules, typically in the context of interactions
  on neural cell membranes and is crucial for neuronal survival and development.<br><br>Upon
  ligand binding, receptor dimers are formed and their intrinsic tyrosine kinase is
  activated causing phosphorylation of multiple tyrosine residues on the receptors.
  These then serve as docking sites for the recruitment of SH2 (src homology-2) or
  PTB (phosphotyrosine binding) domains of adaptors, docking proteins or signaling
  enzymes. Signaling complexes are assembled and recruited to the active receptors
  resulting in a cascade of phosphorylation events.<br><br>This leads to stimulation
  of intracellular signaling pathways that control cell proliferation, cell differentiation,
  cell migration, cell survival and cell shape, depending on the cell type or stage
  of maturation.<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654738
  Reactome].
last-edited: 2020-10-30
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP3338
- /instance/WP3338
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP3338.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: The 22 members of the fibroblast growth factor (FGF) family of growth
    factors mediate their cellular responses by binding to and activating the different
    isoforms encoded by the four receptor tyrosine kinases (RTKs) designated FGFR1,
    FGFR2, FGFR3 and FGFR4. These receptors are key regulators of several developmental
    processes in which cell fate and differentiation to various tissue lineages are
    determined. Unlike other growth factors, FGFs act in concert with heparin or heparan
    sulfate proteoglycan (HSPG) to activate FGFRs and to induce the pleiotropic responses
    that lead to the variety of cellular responses induced by this large family of
    growth factors. An alternative, FGF-independent, source of FGFR activation originates
    from the interaction with cell adhesion molecules, typically in the context of
    interactions on neural cell membranes and is crucial for neuronal survival and
    development.<br><br>Upon ligand binding, receptor dimers are formed and their
    intrinsic tyrosine kinase is activated causing phosphorylation of multiple tyrosine
    residues on the receptors. These then serve as docking sites for the recruitment
    of SH2 (src homology-2) or PTB (phosphotyrosine binding) domains of adaptors,
    docking proteins or signaling enzymes. Signaling complexes are assembled and recruited
    to the active receptors resulting in a cascade of phosphorylation events.<br><br>This
    leads to stimulation of intracellular signaling pathways that control cell proliferation,
    cell differentiation, cell migration, cell survival and cell shape, depending
    on the cell type or stage of maturation.<br>  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=5654738
    Reactome].
  keywords:
  - 'p-8Y-FGFR2b S373C '
  - 'FRS3 '
  - binding
  - Activated FGFR2:FRS3
  - PI(4,5)P2
  - FGFR2:p-FRS3
  - 'UBC(1-76) '
  - 'FGFR2(22-767)-OFD1(38-1012) fusion '
  - HNRNPM
  - 'FGFR2c A314D '
  - splicing complex
  - 'UBB(153-228) '
  - binding FGFs
  - FGFR2:pY-SHC1
  - ESRP2
  - SHC1-2,SHC1-3
  - 'PPP2R1A '
  - FGFR2:p-FRS:p-PTPN11
  - 'p-6Y FGFR2(22-767)-CCDC6(102-474) fusion '
  - 'Activated FGFR2c homodimer bound to FGF '
  - 'p-8Y-FGFR2c A315S mutant '
  - 'p-6Y FGFR2(22-767)-AFF3(292-1226) fusion '
  - 'p-T185,Y187-MAPK1 '
  - 'p-6Y-FRS2 '
  - 'ESRP2 '
  - p-T250,T255,T385,S437-MKNK1
  - 'p-6Y FGFR2(2-822)-CIT(927-2027) fusion '
  - FP-1039
  - 'FGFR2(22-767)-AFF3(292-1226) fusion '
  - 'FGFR2c-binding FGFs '
  - Tyrosine kinase
  - 'p-8Y-FGFR2-5 '
  - 'p-8Y-FGFR2c A315T '
  - Ub:Y55/Y227-pSPRY2:CBL
  - FGFR2b-binding FGFs
  - capped, methylated
  - 'POLR2B '
  - 'FP-1039 '
  - FGFR2:p-FRS2:GRB2:GAB1:PI3K
  - p21 RAS:GDP
  - FGFR2:p-FRS2:p-PTPN11:GRB2:GAB1:PI3K
  - 'RPS27A(1-76) '
  - 'GRB2-1 '
  - 'GalNAc-T178-FGF23(25-251) '
  - bound to FGF
  - 'p-Y194,Y195,Y272-SHC1-3 '
  - 'FGFR2(22-767)-AHCYL1(108-530) fusion '
  - p-S111,S120-SPRY2
  - mutants:PLCG1
  - 'p-Y239,Y240,Y317-SHC1-2 '
  - 'FGF7 '
  - 'S-Farn-Me KRAS4B '
  - FGFR2c mature mRNA
  - SPRY2:B-RAF
  - 'p-6Y FGFR2(22-768)-BICC1(80-974) fusion '
  - Ub
  - 'UBC(229-304) '
  - 'p-8Y-FGFR2 S267P '
  - 'PIK3CA '
  - 'p-8Y-FGFR2 N549H '
  - activated
  - enhanced
  - homodimers
  - 'p-8Y-FGFR2c Y375C '
  - FGFR2:pY-SHC1:GRB2:SOS1
  - GDP
  - 'p-8Y-FGFR2 '
  - mutant-binding FGFs
  - p-SPRY2
  - 'phosphorylated FGFR2 L764fs*4 '
  - Overexpressed FGFR2
  - FRS2
  - GTP
  - dimers:TKIs
  - 'POLR2H '
  - PI(3,4,5)P3
  - 'POLR2C '
  - 'FGF18 '
  - ligand-independent
  - FGF
  - FGFR2 fusion dimers
  - FGFR2:p-FRS2:p-PTPN11:GRB2:GAB1:PIK3R1
  - FGFR2b homodimer
  - Activated FGFR2:FRS2
  - FGFR2:TKIs
  - overexpressed FGFR2
  - FGFR2c homodimer
  - 'UBC(609-684) '
  - FGFR2b
  - 'POLR2D '
  - 'p-S112,S115-SPRY2 '
  - p-Y371-CBL:GRB2
  - 'TIA1 '
  - HNRNPA1
  - 'FGF17-1 '
  - 'FGFR2c long '
  - pre-FGFR2 mRNA:CBC
  - PIP3 activates AKT
  - 'FGFR2c A315T '
  - 'FGFR2c A315S '
  - 'PI(3,4,5)P3 '
  - 'ESRP1 '
  - 'FGFBP3 '
  - 'FGFR2c A314S '
  - 'POLR2E '
  - Activated FGFR2:SHC1
  - 'FRS2 '
  - 'p-8Y-FGFR2c A314S '
  - 'p-6Y FGFR2(22-767)-CASP7(1-303) fusion '
  - FGFR2:p-FRS2:p-PTPN11:p-CBL:GRB2
  - 'p-8Y-FGFR2b S252W '
  - 'GTP '
  - mutants with
  - 'SPRY2 '
  - PLCG1
  - GP369
  - 'FGFR2b S373C '
  - 'FGFR2 W290C '
  - inhibitors of FGFR2
  - ligand-binding
  - PIK3R1
  - FGFR2 point mutant
  - 'FGFR2c short '
  - SRC-1
  - PP2A(A:C):SPRY2
  - 'UBA52(1-76) '
  - 'p-6Y-FGFR2b C3 variant '
  - 'FGFR2 K660M '
  - 'p-8Y-FGFR2 K660M '
  - 'p-Y55,Y227-SPRY2 '
  - 'FGFR2 IIIa TM '
  - 'Activated FGFR2 ligand-independent mutants '
  - 'p-8Y-FGFR2b S376C '
  - 'p-8T-FRS2 '
  - signaling
  - 'FGFR2c W290G '
  - 'p-4Y-PLCG1 '
  - 'HNRNPM '
  - 'UBC(305-380) '
  - complex:Ub-p-FRS2
  - Pi
  - 'Activated FGFR2 mutants with enhanced kinase activity '
  - TM:FGF1,2:FGFR2b,
  - FGFs:FP-1039
  - dimers
  - 'FGFR2 ligand-independent mutant dimers '
  - 'FGF3 '
  - FGFBP
  - 'FGFR2 N549H '
  - 'HNRNPF '
  - 'p-6Y FGFR2(22-767)-OFD1(38-1012) fusion '
  - homodimers:GP369
  - FGFR2:p-4Y-PLCG1
  - 'p-8Y-FGFR2c S372C '
  - Activated FGFR2b
  - 'p-8Y-FGFR2c long '
  - PP2A(A:C):Y55/Y227-pSPRY2
  - 'PPP2CA '
  - 'POLR2K '
  - FGFR2:PLCG1
  - PPA2A (A:C):Y55/Y227
  - FGF1,2
  - 'FGFR2b Y376C '
  - FGFR2:p-FRS:PTPN11
  - 'S-Farn-Me-2xPalmS HRAS '
  - inhibitors of
  - p-SPRY2:B-RAF
  - FGFR2
  - 'Activated FGFR2b homodimer bound to FGF '
  - 'Phosphorylated Fibroblast growth factor receptor 2b short '
  - ADP
  - 'AZ 2171 '
  - p-4Y-PLCG1
  - 'NCBP2 '
  - PP2A (A:C)
  - kinase activity
  - 'FGF2(10-155) '
  - Overexpressed
  - 'FGFR2 N549K '
  - 'FGFR2(22-767)-CCAR(51-923) fusion '
  - Y55/Y227-pSPRY2:CBL
  - ATP
  - 'S-Farn-Me PalmS NRAS '
  - FGFR2 IIIc-specific
  - FGFR2 fusions
  - 'p-8Y-FGFR2 K660N '
  - FGFR2:p-8T-FRS2
  - FGFR2:p-FRS2:p-PTPN11
  - 'FGFR2 K660N '
  - mutant dimers
  - cascade
  - 'HNRNPH1 '
  - CBL
  - FGFR2:p-FRS
  - 'FGF16 '
  - p-SPRY2:GRB2
  - 'p-T202,Y204-MAPK3 '
  - FGFR2c-binding FGFs
  - FGFBP:FGF
  - 'GP369 '
  - 'BRAF '
  - FGFR2 IIIb-specific
  - 'POLR2J '
  - 'UBB(77-152) '
  - hnRNPH1:hnPNPF:RBFOX2
  - 'FGFR2(22-768)-BICC1(80-974) fusion '
  - 'p-Y371-CBL '
  - 'POLR2F '
  - homodimer bound to
  - 'p-Y FGFR2 fusion dimers '
  - 'FGF9 '
  - FGFR2c mutants with
  - 'FGFR2 L764fs*4 '
  - 'FGF4 '
  - 'p-8Y-FGFR2 W290C '
  - 'p-8Y-FGFR2c A314D '
  - 'NCBP1 '
  - 'FGFBP2 '
  - 'FGFR2c P253R '
  - 'AZD4547 '
  - FGFR2b mature mRNA
  - 'FGFR2c S372C '
  - 'FGFR2 mutant dimers with enhanced kinase activity '
  - FGFR2:p-FRS2
  - FGFR2 IIIa TM
  - 'p-Y546,Y584-PTPN11 '
  - 'POLR2I '
  - mutants
  - 'RBFOX2 '
  - 'p-8Y-FGFR2b C382R '
  - 'p-8Y-FGFR2c W290G '
  - 'FGFR2c S252W '
  - 'FGF1 '
  - 'SOS1 '
  - 'p-6Y FGFR2(22-767)-AHCYL1(108-530) fusion '
  - 'p-8Y-FGFR2-3 '
  - 'FGF20 '
  - 'FGFR2(2-822)-CIT(927-2027) fusion '
  - DAG and IP3
  - Activated FGFR2
  - 'capped, methylated FGFR2 nascent transcript '
  - p-T,Y MAPK dimers
  - 'p-6Y FGFR2 (22-767)-CCAR(51-923) fusion '
  - 'FGF6 '
  - mutant-binding
  - BRAF
  - 'GTF2F1 '
  - Activated FGFR2c
  - 'p-8Y-FGFR2 N549K '
  - 'CBL '
  - FGFR2 mutant dimers
  - PIK3CA
  - 'p-S111,S120-SPRY2 '
  - 'UBC(77-152) '
  - 'TIAL1 '
  - 'FGFR2c Y375C '
  - GRB2:GAB1
  - 'POLR2L '
  - GRB2:GAB1:PIK3R1
  - 'FGFR2b C382R '
  - PPA2A
  - 'FGFR2b short '
  - 'FGF8-1 '
  - 'p-8Y-FGFR2 K660E '
  - 'PIK3R1 '
  - 'HS '
  - Ub-Activated FGFR2
  - FGFR2c mutant dimers
  - enhanced ligand
  - 'FGFR2 K660E '
  - FGFR2b mutant dimers
  - 'p-5Y-FRS3 '
  - 'FGFR2b S252W '
  - FGFR2c mutant
  - enhanced kinase
  - activity
  - 'UBC(153-228) '
  - S111/S120
  - 'PTBP1 '
  - 'p-S112,S121-SPRY2 '
  - 'p-8Y-FGFR2c P253R '
  - 'SHC1-3 '
  - 'FGFR2c '
  - (A:C):S112/S115
  - FRS3
  - HS
  - 'FGFR2(22-767)-CASP7(1-303) fusion '
  - 'FGFR2 '
  - 'FGFR2b P253R '
  - 'FGFR2 S267P '
  - 'UBC(381-456) '
  - TIA1/TIAL1
  - 'FGFR2b '
  - 'FGFR2b-binding FGFs '
  - RAF/MAP kinase
  - 'SHC1-2 '
  - 'PLCG1 '
  - 'FGF10 '
  - 'GTF2F2 '
  - 'S-Farn-Me-PalmS KRAS4A '
  - FGFR2:p-FRS:GRB2:SOS1
  - 'Activated overexpressed FGFR2 dimers '
  - p21 RAS:GTP
  - 'UBC(457-532) '
  - PPA2A(A:C):SPRY2
  - 'POLR2A '
  - 'FGF5-1 '
  - Ub-(Y55/Y227)p-SPRY2
  - 'UBB(1-76) '
  - complex
  - GRB2-1
  - 'UBC(533-608) '
  - FGFR2b, FGFR2c
  - PTPN11
  - 'p-8Y-FGFR2c S252W '
  - FGFR2:p-FRS2:GRB2:GAB1:PIK3R1
  - 'HNRNPA1 '
  - 'GDP '
  - with enhanced
  - p-Y FGFR2 fusion
  - 'FGF22 '
  - 'PTPN11 '
  - 'POLR2G '
  - mutants:p-4Y-PLCG1
  - 'p-8Y-FGFR2b P253R '
  - 'GAB1 '
  - PP2A(A:C):S112/S121-pSPRY2
  - 'FGFR2(22-767)-CCDC6(102-474) fusion '
  - Activated
  - FGFR2IIIa
  - 'FGFR2b long '
  - PTBP1
  - FGFR2 mutants with
  - 'FGFBP1 '
  - FGFR2b mutants with
  - ESRP1
  - GRB2-1:SOS1
  - FGFR2c
  - 'PPP2CB '
  - 'FGFR2b C3 variant '
  - bound to FGFs
  - FGF2,7,10,22
  license: CC0
  name: Signaling by FGFR2
seo: CreativeWork
title: Signaling by FGFR2
wpid: WP3338
---